| Literature DB >> 35223131 |
Diana Lim1, Eric S Renteria1, Drake S Sime1, Young Min Ju1, Ji Hyun Kim1, Tracy Criswell1, Thomas D Shupe1, Anthony Atala1, Frank C Marini1, Metin N Gurcan2, Shay Soker1, Joshua Hunsberger3, James J Yoo1.
Abstract
The fields of regenerative medicine and tissue engineering offer new therapeutic options to restore, maintain or improve tissue function following disease or injury. To maximize the biological function of a tissue-engineered clinical product, specific conditions must be maintained within a bioreactor to allow the maturation of the product in preparation for implantation. Specifically, the bioreactor should be designed to mimic the mechanical, electrochemical and biochemical environment that the product will be exposed to in vivo. Real-time monitoring of the functional capacity of tissue-engineered products during manufacturing is a critical component of the quality management process. The present review provides a brief overview of bioreactor engineering considerations. In addition, strategies for bioreactor automation, in-line product monitoring and quality assurance are discussed.Entities:
Keywords: Bioreactor; Manufacturing; Monitoring sensors and automation; Regenerative medicine; Tissue engineering
Year: 2021 PMID: 35223131 PMCID: PMC8870603 DOI: 10.1007/s42242-021-00154-3
Source DB: PubMed Journal: Biodes Manuf ISSN: 2096-5524